<DOC>
	<DOCNO>NCT00408304</DOCNO>
	<brief_summary>The purpose study check whether development depression side effect interferon alpha treatment chronic carrier hepatitis C prevent omega-3 fatty acid .</brief_summary>
	<brief_title>Prevention Depression With Omega-3 Fatty Acids Chronic Carriers Hepatitis C Treated With Interferon Alpha .</brief_title>
	<detailed_description>Omega-3 fatty acid know alternative treatment different condition , include mental condition , depression . We assume combine omega-3 treatment interferon alpha may prevent development depression , quite common side effect interferon alpha .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Chronic carrier hepatitis C start course interferon alpha treatment , treat liver clinic Bnai Zion hospital . Disagreement participation trial . Diagnosed active mental illness . Encephalopathic patient . Patients limited ability understand questionnaire inform consent process .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>interferon alpha</keyword>
	<keyword>depression</keyword>
	<keyword>omega 3</keyword>
</DOC>